CBUS Stock’s Brief Rally Masks Rising Short‑Interest and Volatile Market Reality
Explore why Cibus (CBUS)’s recent rally is just a blip: high short‑interest, thin liquidity, and unproven biotech revenue‑growth threaten sustainable upside.
3 minutes to read